human
cytomegaloviru
major
immedi
earli
protein
critic
driver
viru
replic
consid
pivot
determin
balanc
product
latent
infect
deriv
primari
transcript
altern
splice
regul
express
like
involv
complex
interplay
cellular
viral
factor
show
knockdown
host
ubiquitindepend
segregas
result
loss
express
subsequ
suppress
earli
late
gene
express
ultim
failur
viru
replic
rnaseq
analysi
show
increas
level
splice
correspond
decreas
splice
follow
vcp
knockdown
global
analysi
viral
transcript
show
express
subset
viral
gene
reduc
despit
loss
express
includ
furthermor
immunofluoresc
studi
demonstr
vcp
strongli
colocalis
viral
replic
compart
nucleu
final
show
small
molecul
inhibitor
vcp
potent
hcmv
antivir
potenti
novel
host
target
therapeut
hcmv
infect
virus
oblig
intracellular
pathogen
mean
complet
depend
host
cellular
machineri
replic
identifi
host
gene
necessari
viru
replic
extend
understand
virus
replic
cell
function
provid
potenti
target
novel
antivir
show
cellular
factor
call
valosin
contain
protein
vcp
essenti
human
cytomegaloviru
replic
demonstr
vcp
requir
express
essenti
viru
gene
call
final
show
chemic
inhibitor
vcp
potent
antivir
human
cytomegaloviru
demonstr
potenti
vcp
inhibitor
novel
therapeut
viru
human
cytomegaloviru
hcmv
highli
preval
herpesviru
infect
global
popul
depend
socioeconom
statu
although
normal
asymptomat
healthi
individu
hcmv
infect
signific
caus
morbid
mortal
immunocompromis
popul
individu
heart
diseas
recipi
solid
organ
bone
marrow
transplant
hcmv
also
lead
caus
infecti
congenit
birth
defect
infect
hcmv
initi
program
cascad
gene
express
result
product
infecti
viru
two
first
gene
express
major
immedi
earli
mie
gene
mie
protein
multipl
role
infect
includ
transactiv
viral
gene
drive
replic
viru
product
thought
play
pivot
role
control
switch
latent
product
infect
hcmv
requir
effici
viru
replic
low
multipl
infect
express
essenti
delet
result
nonviabl
viru
gener
primari
transcript
differenti
splice
altern
polyadenyl
share
first
three
exon
splice
fourth
fifth
exon
determin
express
transcript
respect
fig
independ
polyadenyl
signal
exist
downstream
exon
four
exon
five
genom
arrang
requir
termin
exon
skip
consid
rel
unusu
host
cell
specif
factor
mechan
involv
regul
process
fulli
understood
valosin
contain
protein
vcp
belong
hexamer
aaa
atpas
famili
play
pivot
role
ubiquitin
mediat
signal
remodel
target
protein
often
lead
proteosom
degrad
vcp
contain
two
atpas
domain
hydrolyz
atp
gener
energi
requir
remodel
unfold
target
protein
action
vcp
abl
segreg
target
protein
associ
cellular
membran
larger
protein
complex
segreg
target
protein
relocalis
degrad
via
proteosom
complex
vcp
also
affect
protein
modifi
interact
multipl
ubiquitin
regulatori
cofactor
make
vcp
central
signal
hub
ubiquitin
mediat
regul
addit
ubiquitin
vcp
link
posttransl
modifi
sumo
link
wide
rang
biolog
function
includ
protein
qualiti
control
autophagi
chromatin
remodel
dna
damag
respons
recent
rna
process
function
vcp
play
central
role
protein
homeostasi
facilit
proteosom
degrad
misfold
damag
protein
part
endoplasm
reticulum
associ
degrad
pathway
erad
addit
role
protein
degrad
vcp
link
nondegrad
function
involv
remov
reloc
protein
membran
protein
complex
exampl
includ
remov
aurora
b
protein
mitot
chromosom
remov
transcript
factor
chromatin
disassembl
rnp
complex
also
link
number
function
role
viru
replic
includ
entri
sindbi
viru
replic
polioviru
vcp
play
role
degrad
mhc
class
protein
hcmv
infect
direct
role
vcp
replic
hcmv
previous
report
use
focus
sirna
screen
identifi
vcp
essenti
factor
hcmv
replic
show
vcp
essenti
onset
viru
replic
knockdown
vcp
result
chang
altern
splice
mie
transcript
loss
express
ultim
failur
viru
replic
previous
identifi
host
gene
critic
factor
hcmv
viru
product
compon
vacuolar
atpas
among
function
involv
membran
organ
identifi
addit
host
membran
organ
factor
involv
hcmv
replic
perform
focus
sirna
screen
host
gene
involv
membran
organ
use
pool
four
sirna
target
primari
human
fibroblast
cell
doubl
transfect
sirna
pool
well
format
two
day
posttransfect
cell
infect
low
passag
hcmv
strain
express
gfp
promot
gfp
level
monitor
period
seven
day
fluorometri
determin
viru
infect
replic
level
tabl
analysi
screen
indic
increas
decreas
viru
replic
rang
reduct
gfp
level
increas
fig
zscore
analysi
base
three
biolog
repeat
sirna
screen
identifi
five
clear
outlier
result
reproduc
reduct
viru
replic
measur
gfp
fluoresc
intens
fig
knockdown
vcp
result
largest
neg
zscore
valid
observ
phenotyp
due
knockdown
vcp
rather
potenti
offtarget
effect
origin
sirna
pool
deconvolut
test
four
individu
sirna
vcp
four
sirna
result
reduc
vcp
express
reduc
hcmv
replic
base
gfp
fluoresc
fig
third
sirna
pool
gener
less
effici
vcp
knockdown
correspond
less
inhibit
hcmv
sirna
assay
provid
addit
evid
knockdown
vcp
result
direct
reduct
viru
replic
result
indic
initi
observ
phenotyp
due
specif
knockdown
vcp
rather
offtarget
artefactu
effect
sirna
although
gfp
express
serv
effect
readout
viru
replic
loss
gfp
signal
may
necessarili
reflect
reduc
viru
product
determin
direct
effect
vcp
knockdown
hcmv
viru
product
onestep
growth
curv
gener
primari
human
fibroblast
cell
transfect
sirna
pool
target
vcp
neg
control
nontarget
sirna
two
day
post
transfect
cell
infect
multipl
infect
moi
three
supernat
collect
time
point
seven
day
total
knockdown
vcp
result
signific
reduct
hcmv
replic
viral
titer
four
log
lower
cell
deplet
vcp
compar
neg
control
cell
day
seven
fig
amplif
infecti
viru
observ
cell
knock
vcp
suggest
complet
block
viru
replic
cell
viabil
assay
show
moder
decreas
cell
viabil
day
post
transfect
vcp
sirna
compar
neg
control
sirna
although
visual
inspect
cell
indic
gross
cytotox
reduct
suffici
account
substanti
reduct
viru
replic
fig
vcp
requir
express
express
character
perform
determin
stage
hcmv
replic
cycl
vcp
requir
analysi
gfp
fluoresc
hour
post
infect
hpi
indic
cell
infect
demonstr
vcp
express
requir
viru
entri
transloc
genom
nucleu
initi
transcript
viral
genom
fig
western
blot
analysi
perform
measur
level
major
kinet
class
hcmv
gene
includ
immedi
earli
earli
late
defin
disrupt
viru
replic
occur
fig
control
cell
protein
express
class
viru
gene
clearli
observ
howev
cell
knock
vcp
neither
downstream
viral
gene
express
detect
strikingli
despit
encod
primari
transcript
express
level
higher
rel
control
cell
day
four
post
infect
data
indic
vcp
express
requir
onset
hcmv
replic
suggest
knockdown
vcp
affect
express
major
immedi
earli
gene
knockdown
vcp
result
specif
loss
hypothes
vcp
may
play
role
protein
stabil
transcript
stabil
regul
altern
splice
polyadenyl
determin
whether
vcp
requir
protein
stabil
inhibit
two
main
pathway
protein
degrad
use
proteasom
inhibitorubiquitin
depend
pepstatin
proteas
inhibitorsubiquitin
independ
context
vcp
knockdown
fig
vcp
regul
due
protein
degrad
inhibit
pathway
rescu
protein
level
neither
pepstatin
rescu
loss
protein
level
follow
knockdown
vcp
instead
higher
concentr
phenocopi
vcp
knockdown
control
cell
indic
proteosom
function
requir
gene
express
vcp
target
ubiquitin
protein
proteosom
degrad
result
suggest
intermedi
protein
target
vcp
may
inhibit
express
consist
previou
public
show
inhibit
proteasom
reduc
express
hcmv
replic
determin
whether
regul
mie
gene
occur
rna
level
northern
blot
analysi
perform
fibroblast
cell
transfect
sirna
vcp
control
sirna
infect
post
transfect
high
moi
total
rna
harvest
hpi
shown
fig
knockdown
vcp
result
substanti
reduct
rna
level
hpi
includ
smaller
speci
result
confirm
qrtpcr
use
primer
specif
transcript
supplement
fig
demonstr
clear
differ
kinet
transcript
accumul
control
cell
transcript
level
rapidli
increas
follow
infect
level
initi
increas
plateau
hpi
accumul
substanti
higher
level
hpi
onward
accumul
fail
occur
follow
knockdown
vcp
level
substanti
increas
hpi
contrast
control
cell
fig
mie
transcript
also
affect
earlier
time
point
level
reduc
hpi
increas
hpi
fig
increas
rna
level
hpi
may
result
increas
mie
promot
activ
due
associ
loss
protein
express
earli
time
point
neg
regul
mie
promot
transcript
level
decreas
rapidli
hpi
protein
level
remain
high
suggest
protein
stabl
increas
transcript
hour
may
contribut
prolong
increas
protein
level
result
suggest
vcp
may
affect
aspect
mie
transcript
howev
northern
western
qrtpcr
data
consist
substanti
effect
express
hpi
onward
determin
whether
loss
vcp
result
specif
destabil
transcript
rna
level
measur
follow
treatment
cell
actinomycin
hpi
actinomycin
inhibit
rna
polymeras
block
new
transcript
allow
monitor
transcript
stabil
time
total
rna
harvest
indic
time
point
transcript
level
determin
northern
blot
analysi
calcul
halflif
transcript
indic
stabil
modestli
increas
fold
respect
suggest
loss
vcp
result
transcript
destabil
fig
defin
chang
altern
splice
challeng
multipl
factor
includ
promot
activ
rna
stabil
viral
genom
amplif
contribut
increas
decreas
total
mrna
level
determin
whether
knockdown
vcp
alter
differenti
splice
mie
region
rnaseq
analysi
perform
allow
direct
comparison
read
count
first
three
share
exon
mie
transcript
specif
exon
four
five
respect
control
chang
promot
activ
effect
genom
amplif
therefor
base
current
understand
rna
process
chang
absolut
ratio
exon
four
five
share
exon
must
due
chang
splice
chang
rna
stabil
cell
transfect
vcp
sirna
neg
control
sirna
infect
hcmv
moi
three
total
rna
harvest
hpi
subject
strandspecif
pairedend
illumina
sequenc
annot
exon
major
immedi
earli
region
clearli
appar
map
read
six
sampl
read
correspond
splice
junction
consist
previou
data
region
indic
splice
share
exon
one
three
splice
exon
three
four
result
transcript
three
five
result
transcript
fig
consist
northern
blot
qrtpcr
data
mie
transcript
increas
hpi
decreas
hpi
follow
knockdown
vcp
fig
furthermor
splice
mie
primari
transcript
heavili
bias
toward
hour
splice
increas
infect
progress
fig
determin
whether
knockdown
vcp
alter
balanc
splice
proport
total
read
map
five
exon
ie
region
calcul
tabl
fig
repr
sent
absolut
differ
exon
frequenc
vcp
knockdown
sampl
compar
neg
control
sampl
hpi
knockdown
vcp
effect
rel
proport
read
map
exon
four
five
howev
hpi
clear
increas
rel
proport
read
map
exon
four
vcp
knockdown
sampl
correspond
decreas
exon
five
read
frequenc
contrast
knockdown
vcp
effect
rel
proport
read
map
share
exon
indic
reduc
splice
exon
three
five
correspond
increas
splice
exon
three
four
knockdown
vcp
also
result
lower
frequenc
read
pair
span
exon
three
five
splice
junction
correspond
increas
read
pair
span
exon
three
four
splice
junction
fig
fig
tabl
result
show
knockdown
vcp
alter
splice
mie
transcript
result
failur
switch
splice
splice
determin
whether
knockdown
vcp
result
gener
effect
viru
transcript
splice
analys
read
count
wellcharacter
hcmv
splice
transcript
fig
base
exon
count
show
similar
pattern
mie
transcript
respons
vcp
knockdown
absolut
exon
frequenc
exon
increas
correspond
decreas
exon
read
frequenc
howev
unlik
mie
transcript
analysi
pairedend
read
support
substanti
splice
exon
exon
fig
instead
exon
exon
like
predominantli
independ
transcript
unit
differ
kinet
exon
requir
express
transactiv
determin
effect
vcp
knockdown
global
viral
gene
express
read
count
map
entir
viral
genom
shown
supplement
fig
total
read
count
map
viral
genom
rel
similar
hpi
howev
viral
gene
express
increas
control
cell
approxim
fold
hpi
express
vcp
knockdown
cell
increas
indic
gener
reduct
viral
gene
express
follow
vcp
knockdown
unsurpris
given
vital
role
protein
play
transactiv
viral
gene
express
determin
whether
knockdown
vcp
result
similar
effect
viral
gene
differenti
effect
total
read
map
individu
viral
open
read
frame
viral
gene
express
compar
control
cell
vcp
knockdown
cell
fig
tabl
hpi
moder
reduct
viral
gene
express
observ
subset
transcript
express
rel
higher
level
follow
vcp
knockdown
particular
proport
total
read
map
five
exon
calcul
absolut
differ
valu
vcp
knockdown
correspond
neg
control
shown
number
within
exon
knockdown
vcp
effect
proport
read
origin
exon
associ
greater
proport
read
deriv
exon
decreas
number
exon
b
log
ratio
proport
read
map
exon
whose
match
pair
map
either
exon
shown
proport
read
pair
span
share
splice
junction
exon
two
three
unaffect
vcp
knockdown
wherea
exon
frequenc
increas
decreas
http
express
level
mie
transcript
rel
higher
vcp
knockdown
cell
compar
control
cell
howev
hpi
profound
global
suppress
viru
gene
express
vcp
knockdown
cell
particularli
appar
noncod
gene
rna
gene
highli
regul
later
stage
infect
includ
despit
loss
express
express
subset
viral
gene
remain
equival
control
level
follow
knockdown
vcp
fig
fig
includ
particularli
surpris
previous
identifi
target
transactiv
vcp
essenti
hcmv
replic
alter
mie
splice
due
chang
cell
cycl
delay
replic
progress
follow
vcp
knockdown
previou
studi
shown
cell
cycl
impact
regul
mie
altern
splice
splice
viru
replic
block
phase
furthermor
cyclin
depend
kinas
requir
effici
express
cyclin
overexpress
inhibit
splice
viru
replic
determin
whether
knockdown
vcp
result
alter
cell
cycl
turn
regul
mie
splice
cell
stain
propidium
iodid
follow
vcp
knockdown
result
clearli
show
knockdown
vcp
gross
effect
cell
cycl
control
fig
consist
major
cell
phase
cyclin
level
remain
undetect
western
blot
control
vcp
knockdown
cell
fig
result
show
regul
mie
splice
vcp
consequ
alter
cell
cycl
control
instead
repres
novel
regulatori
pathway
determin
whether
effect
vcp
mie
express
could
result
simpl
delay
inhibit
progress
viru
replic
compar
mie
protein
transcript
level
follow
treatment
cell
ganciclovir
well
character
drug
inhibit
viral
dna
synthesi
ganciclovir
treatment
vcp
knockdown
result
substanti
reduct
gene
express
knockdown
vcp
result
correspond
increas
gene
express
rel
chang
splice
fig
furthermor
contrast
vcp
knockdown
express
could
detect
four
day
post
infect
follow
ganciclovir
treatment
data
suggest
alter
mie
level
caus
vcp
knockdown
artifact
delay
viru
replic
previou
studi
demonstr
vcp
play
import
role
cytoplasm
hcmv
infect
cell
mediat
degrad
mhc
class
strip
protein
er
membran
ubiquitin
depend
manner
determin
cellular
localis
vcp
hcmv
infect
primari
fibroblast
cell
infect
high
moi
hcmv
fix
time
point
stain
vcp
shown
fig
vcp
display
dynam
tempor
cellular
localis
hcmv
infect
uninfect
cell
vcp
stain
result
diffus
signal
throughout
cell
howev
follow
infect
hcmv
distinct
puncta
observ
nucleu
infect
cell
hpi
vcp
consist
found
within
two
larg
puncta
within
nucleu
increas
size
hour
stain
characterist
viral
replic
compart
follow
infect
hcmv
viral
genom
deposit
adjac
domain
form
two
distinct
replic
compart
within
nucleu
character
colocalis
viral
dna
dna
replic
protein
protein
therefor
vcp
localis
viru
replic
compart
nucleu
coincid
increas
express
given
vcp
essenti
hcmv
replic
investig
whether
small
molecul
inhibitor
vcp
viabl
antivir
candid
vcp
potenti
anticanc
target
number
effect
small
molecul
inhibitor
vcp
develop
highli
potent
select
inhibitor
vcp
determin
whether
treatment
infect
cell
result
phenotyp
vcp
sirna
knockdown
cell
pretreat
dmso
infect
high
moi
hcmv
total
protein
harvest
everi
hour
total
five
day
subject
western
blot
analysi
shown
fig
treatment
recapitul
phenotyp
effect
vcp
sirna
loss
transcript
protein
express
contrast
sirna
knockdown
vcp
treatment
result
increas
express
may
due
addit
target
effect
drug
compar
sirna
knockdown
consequ
inhibit
activ
vcp
compar
directli
knock
protein
next
compar
antivir
activ
ganciclovir
current
commonli
use
hcmv
antivir
primari
human
fibroblast
cell
pretreat
differ
concentr
ganciclovir
dmso
control
cell
supernat
harvest
seven
day
post
infect
plaqu
assay
shown
fig
ganciclovir
clearli
inhibit
product
infecti
viru
howev
display
higher
level
potenc
tenfold
lower
concentr
compar
ganciclovir
cotreat
cell
time
infect
also
result
reduc
level
similar
reduct
infecti
viru
fig
fig
contrast
treat
cell
hpi
reduc
express
viru
product
extent
fig
fig
immedi
earli
earli
viral
gene
express
substanti
affect
treatment
cell
hour
post
infect
express
late
gene
substanti
reduc
infecti
viru
reduc
fold
suggest
vcp
may
also
involv
late
process
viru
replic
consist
pleiotrop
natur
vcp
potenti
affect
hcmv
replic
multitud
way
treatment
also
show
littl
toxic
effect
concentr
fig
suggest
small
molecul
inhibitor
vcp
show
signific
potenti
hcmv
antivir
therapi
vcp
play
pivot
role
ubiquitindepend
signal
remodel
target
protein
often
lead
proteosom
degrad
link
wide
rang
biolog
function
includ
protein
qualiti
control
autophagi
chromatin
remodel
recent
rna
process
follow
systemat
screen
host
gene
involv
membran
organ
identifi
vcp
critic
host
factor
hcmv
replic
character
demonstr
knockdown
vcp
result
initi
increas
mie
transcript
follow
substanti
reduct
express
major
immedi
earli
transcript
strikingli
despit
express
primari
transcript
level
increas
follow
vcp
knockdown
data
also
suggest
vcp
play
role
late
stage
viru
replic
inhibit
vcp
hpi
substanti
affect
express
still
result
twolog
reduct
infecti
viru
given
function
pleotrop
natur
vcp
unsurpris
knockdown
result
multifactori
effect
viru
potenti
reflect
divers
role
ubiquitin
modul
signal
viru
infect
viral
gene
express
hcmv
replic
occur
tightli
regul
cascad
mechan
express
mie
gene
particular
requir
transactiv
earli
viral
gene
subsequ
late
viral
gene
express
due
central
role
mie
protein
drive
replic
viru
suggest
play
pivot
role
regul
balanc
product
latent
infect
gener
primari
transcript
altern
splice
share
first
three
exon
splice
independ
final
exon
rel
unusu
process
termin
exon
skip
consist
previou
public
data
show
express
level
increas
rapidli
due
preferenti
splice
termin
exon
result
lower
level
transcript
plateau
hpi
fig
infect
progress
splice
termin
exon
increas
correspond
decreas
splice
regul
altern
splice
mie
transcript
therefor
crucial
determin
whether
replic
viru
progress
express
depend
switch
splice
although
time
precis
splice
pattern
mie
region
well
document
splice
regul
downstream
consequ
viru
replic
poorli
understood
howev
like
depend
complex
interplay
cellular
viral
factor
architectur
mie
transcript
region
express
mie
transcript
splice
intim
link
multipl
factor
includ
cell
cycl
cell
type
differenti
statu
suppress
mie
transcript
hcmv
infect
myeloid
cultur
thought
key
establish
latent
infect
convers
activ
differenti
latent
infect
cell
result
upregul
mie
gene
express
subsequ
reactiv
infect
fibroblast
cell
express
mie
transcript
replic
close
link
cell
cycl
statu
mie
express
suppress
phase
suppress
due
part
cyclin
alter
splice
mie
transcript
manner
similar
knockdown
vcp
result
loss
express
failur
viru
replic
express
cyclin
result
similar
phenotyp
data
show
vcp
knockdown
caus
gross
chang
cell
cycl
increas
cyclin
express
indic
altern
mechan
action
although
major
research
vcp
focus
cytoplasm
activ
recent
studi
identifi
equal
import
divers
role
vcp
nucleu
associ
vcp
viral
replic
compart
earli
infect
suggest
nuclear
function
vcp
may
play
critic
role
hcmv
replic
studi
yeast
mammalian
cell
line
demonstr
vcp
modul
associ
factor
chromatin
lead
regul
cell
cycl
transcript
dna
replic
dna
damag
respons
could
potenti
affect
viru
replic
mie
express
previou
report
shown
hcmv
induc
host
dna
damag
respons
respons
factor
includ
atm
requir
effici
hcmv
replic
express
also
colocalis
viral
replic
compart
nucleu
vcp
act
downstream
atm
requir
remov
ubiquitin
factor
associ
dsdna
break
region
allow
repair
proceed
knockdown
vcp
disrupt
dna
damag
respons
hcmv
infect
could
contribut
observ
loss
express
inhibit
viru
replic
report
also
emerg
vcp
play
role
transcript
stabil
regul
splice
hur
rna
bind
protein
stabil
transcript
bind
canon
au
rich
region
within
follow
ubiquitin
hur
respons
stress
signal
vcp
remov
hur
associ
transcript
result
transcript
destabil
drosophila
vcp
link
dendrit
prune
neuron
cell
express
mutant
form
vcp
result
incorrect
splice
gene
import
dendrit
prune
mical
possibl
mislocalis
rna
bind
protein
given
known
mechan
action
vcp
like
effect
mie
splice
indirect
occur
target
ubiquitin
intermedi
protein
one
possibl
model
neg
regul
splice
exist
earli
stage
hcmv
infect
promot
express
expens
express
base
transcript
architectur
major
immedi
region
factor
could
regul
mie
splice
promot
polyadenyl
transcript
therebi
inhibit
readthrough
final
exon
factor
would
ubiquitin
remov
vcp
hpi
allow
readthrough
first
polyadenyl
site
splice
transcript
would
consist
initi
plateau
transcript
localis
vcp
replic
compart
hpi
spliceosom
proteasom
compon
also
report
colocalis
data
also
support
model
inhibit
express
effect
either
pretreat
addit
drug
time
infect
treatment
hpi
ineffect
block
express
suggest
window
vcp
activ
requir
regul
mie
splice
interestingli
block
de
novo
protein
translat
cycloheximid
treatment
effect
rescu
transcript
follow
treatment
suggest
inhibitori
factor
induc
viru
infect
fig
although
common
number
exampl
termin
exon
skip
human
genom
would
analog
propos
model
matur
b
cell
differenti
plasma
cell
result
switch
predominantli
membran
bound
igm
secret
igm
studi
shown
increas
express
polyadenyl
factor
promot
polyadenyl
upstream
exon
requir
membran
bound
igm
result
increas
express
secret
form
tissu
specif
regul
calcitonin
peptid
also
regul
differenti
polyadenyl
embed
termin
exon
splice
factor
bind
polya
enhanc
sequenc
direct
polyadenyl
upstream
polya
site
recruit
polya
factor
restrict
activ
result
remov
upstream
termin
exon
splice
enhanc
express
downstream
termin
exon
exampl
splice
directli
link
cellular
differenti
case
igm
tissu
specif
case
calcitonin
factor
fundament
regul
hcmv
latenc
cell
type
specif
determin
site
latenc
differenti
latent
infect
cell
link
reactiv
given
central
role
determin
viru
replic
link
regul
mie
splice
cellular
differenti
tissu
specif
would
potent
mechan
regul
establish
mainten
reactiv
latenc
hcmv
experi
current
underway
determin
whether
regul
mie
splice
vcp
follow
similar
paradigm
cellular
exampl
whether
regul
involv
hcmv
latenc
final
vcp
clearli
essenti
viru
replic
small
molecul
inhibitor
vcp
potenti
attract
antivir
candid
hcmvrelat
ill
account
diseas
associ
solid
organ
transplant
patient
prolong
treatment
especi
patient
sever
suppress
immun
system
greatli
increas
risk
antivir
resist
antivir
develop
use
hcmv
sinc
licens
ganciclovir
viral
gene
target
reduc
like
use
drug
resist
strain
altern
strategi
develop
novel
antivir
involv
target
host
gene
requir
viru
success
replic
vcp
identifi
potenti
anticanc
target
number
small
molecul
inhibitor
develop
potent
show
time
potent
ganciclovir
equival
concentr
littl
sign
toxic
activ
level
whether
drug
toxic
vivo
remain
determin
delet
vcp
transgen
mice
nonviabl
natur
occur
mutat
human
link
sever
development
defect
howev
transient
inhibit
vcp
small
molecul
inhibitor
may
viabl
treatment
option
especi
patient
resist
current
antivir
pose
signific
risk
health
normal
human
dermal
fibroblast
nhdf
gibco
maintain
dulbecco
modifi
high
glucos
media
dmem
sigma
supplement
fetal
bovin
serum
fb
gibco
penicillinstreptomycin
invitrogen
low
passag
hcmv
strain
express
gfp
promot
use
sirna
librari
screen
western
blot
analysi
northern
blot
analysi
laboratori
adapt
hcmv
strain
use
immunofluoresc
experi
human
sigenom
sirna
librari
target
membran
traffick
gene
sirna
per
gene
dharmacon
inc
select
gene
includ
primari
screen
brief
nhdf
seed
plate
day
sirna
transfect
next
day
cell
reach
confluenc
transfect
sirna
twice
hour
apart
first
second
transfect
use
lipofectamin
rnaimax
invitrogen
accord
manufactur
protocol
transfect
nhdf
incub
hour
infect
gfp
express
viru
moi
three
gfp
intens
monitor
everi
hour
synergi
ht
micropl
reader
biotek
entir
screen
perform
duplic
repeat
three
time
vcp
gene
identifi
primari
screen
subsequ
silenc
four
individu
sirna
elimin
possibl
phenotyp
associ
target
effect
cell
lyse
ripa
buffer
sd
triton
deoxychol
mm
edta
mm
nacl
mm
tri
ph
contain
proteas
inhibitor
cocktail
roch
ten
microgram
total
lysat
separ
sdspolyacrylamid
gel
transfer
pvdf
membran
millipor
primari
antibodi
use
paper
mous
anticmv
monoclon
antibodi
millipor
mous
anticmv
monoclon
antibodi
santa
cruz
biotechnolog
mous
anticmv
monoclon
antibodi
santa
cruz
biotechnolog
rabbit
antivcp
polyclon
antibodi
santa
cruz
biotechnolog
mous
monoclon
antibodi
abcam
blot
probe
primari
antibodi
dilut
dehydr
milk
tri
buffer
salin
tb
subsequ
hrpconjug
secondari
antibodi
pierc
blot
wash
tb
three
time
incub
chemiluminesc
substrat
supersign
west
pico
thermo
scientif
accord
manufactur
protocol
expos
g
box
syngen
visual
band
total
rna
isol
use
trizol
solut
accord
manufactur
protocol
northern
blot
analysi
mrna
conduct
use
total
rna
separ
agaros
formaldehyd
gel
transfer
use
whatman
turboblott
rapid
downward
transfer
system
probe
gener
pcr
use
cdna
infect
nhdf
templat
label
amersham
rediprim
ii
dna
label
system
ge
healthcar
follow
primer
tcaaacagattaaggt
tcgagtgg
atccacatctcccgcttatcctcg
tcatggtgcgcatcttc
tccacc
ttactgagacttgttcctcaggtcc
hybrid
wash
membran
expos
autoradiographi
film
intensifi
screen
biomax
transcreen
kodak
visual
band
cell
transfect
infect
describ
total
rna
harvest
use
trizol
accord
manufactur
guidelin
total
rna
submit
edinburgh
genom
gener
truseq
strand
librari
subject
hiseq
high
output
sequenc
strandspecif
rnaseq
read
map
combin
version
human
human
herpesviru
genom
use
hisat
splice
read
mapper
valid
read
pair
map
togeth
correct
orient
retain
ie
carri
sam
flag
one
custom
perl
script
use
count
number
read
map
exon
well
number
read
pair
span
differ
combin
exon
drug
inhibitor
studi
cytotox
assay
xcess
bioscienc
ganciclovir
cambridg
bioscienc
dissolv
dmso
ad
cell
cultur
work
concentr
hour
hcmv
infect
viabil
treat
cell
assess
use
celltiterglo
luminesc
cell
viabil
assay
kit
promega
celltiterblu
promega
hour
addit
cambridg
bioscienc
pepstatin
sigma
sigma
dissolv
dmso
ad
cell
cultur
hour
hcmv
infect
cycloheximid
dmso
sigma
ad
cell
cultur
minut
hcmv
infect
block
protein
biosynthesi
laboratori
adapt
hcmv
strain
infect
cell
fix
permeabil
methanol
aceton
solut
minut
block
human
serum
pb
minut
primari
secondari
antibodi
dilut
human
serum
pb
cell
wash
pb
primari
secondari
antibodi
incub
primari
antibodi
use
paper
mous
anticmv
monoclon
antibodi
santa
cruz
biotechnolog
rabbit
antivcp
polyclon
antibodi
santa
cruz
biotechnolog
conjug
goat
antimous
conjug
goatantirabbit
igg
secondari
antibodi
dilut
imag
acquir
zeiss
lsm
confoc
microscop
fit
oilimmers
object
len
total
rna
isol
use
trizol
solut
accord
manufactur
protocol
follow
dnase
turbo
dnafre
kit
ambion
treatment
revers
transcrib
poli
primer
use
high
capac
cdna
revers
transcript
kit
invitrogen
realtim
pcr
carri
use
taqman
assay
predesign
genespecif
primerprob
set
appli
biosystem
rotor
gene
corbet
research
custom
primerprob
set
cgtcaaacagattaaggttcgagtgg
ccacatctcccgcttatcctcg
atggtgcgcatcttctccacc
ttactgagacttgttcctcaggtcctg
cell
harvest
trypsin
wash
pb
follow
fix
cold
ethanol
minut
fix
cell
wash
twice
pb
treat
rnasea
label
propidium
iodid
mgml
stock
solut
sigma
cell
cycl
analysi
first
carri
use
bd
lsrfortessa
analyz
use
flowjo
softwar
quantif
differ
protein
level
knockdown
vcp
versu
ganciclovir
treatment
quantif
compar
neg
control
time
point
rel
transcript
level
normalis
mie
share
exon
level
determin
qrtpcr
use
primer
probe
specif
exon
exon
exon
exon
level
normalis
exon
vcp
knockdown
cell
cell
treat
ganciclovir
cell
treat
cycloheximid
minut
prior
infect
block
de
novo
protein
synthesi
total
rna
harvest
indic
time
transcript
level
determin
northern
blot
analysi
docx
tabl
sirna
screen
data
raw
data
three
repeat
sirna
screen
includ
technic
repeat
averag
three
experi
well
z
score
standard
deviat
shown
xlsx
tabl
exon
read
count
ratio
total
read
count
five
exon
condit
shown
along
ratio
total
calcul
differenti
neg
control
vcp
knockdown
sampl
xlsx
tabl
splice
junction
count
total
read
count
across
mie
junction
shown
along
ratio
calcul
defin
differenti
exon
log
xlsx
tabl
rel
express
level
exon
significantli
depend
combin
timepoint
vcp
statu
linear
model
result
test
associ
rel
express
level
exon
time
sivcp
treatment
rel
express
level
measur
proport
transcript
read
map
correspond
exon
sampl
coeffici
standard
error
bracket
p
valu
shown
associ
rel
express
level
exon
timepoint
depend
vcp
statu
demonstr
signific
interact
term
time
sivcp
